| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 34.19B | 34.06B | 33.40B | 31.79B | 26.99B | 26.00B |
| Gross Profit | 5.01B | 4.69B | 4.51B | 3.75B | 2.55B | 2.57B |
| EBITDA | 3.40B | 3.12B | 2.83B | 2.13B | 1.04B | 1.15B |
| Net Income | 1.72B | 1.42B | 1.68B | -718.77M | -801.05M | 106.40M |
Balance Sheet | ||||||
| Total Assets | 32.39B | 32.92B | 31.63B | 29.17B | 31.64B | 31.40B |
| Cash, Cash Equivalents and Short-Term Investments | 8.66B | 8.41B | 7.09B | 6.91B | 8.27B | 10.23B |
| Total Debt | 226.10M | 286.29M | 324.36M | 182.33M | 207.61M | 199.14M |
| Total Liabilities | 8.66B | 8.97B | 9.73B | 10.02B | 8.29B | 8.11B |
| Stockholders Equity | 21.78B | 21.96B | 19.94B | 17.32B | 21.64B | 21.55B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.44B | 275.59M | 2.49B | -1.83B | 21.49M |
| Operating Cash Flow | 0.00 | 2.25B | 1.34B | 3.50B | -180.84M | 1.18B |
| Investing Cash Flow | 0.00 | -599.38M | -1.26B | -908.80M | -991.40M | -1.29B |
| Financing Cash Flow | 0.00 | -410.82M | -311.45M | -3.99B | -622.34M | -368.68M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥13.25B | 7.18 | ― | 4.02% | 2.31% | 10.68% | |
75 Outperform | ¥499.84B | 7.76 | 8.58% | 2.62% | 1.44% | -0.92% | |
71 Outperform | ¥47.80B | 4.34 | ― | 3.60% | 0.14% | 882.91% | |
67 Neutral | ¥5.32T | 10.20 | 6.98% | 2.98% | 2.41% | 11.03% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
54 Neutral | ¥1.71T | 14.23 | 8.34% | 2.03% | 4.33% | 524.86% | |
48 Neutral | ¥19.59B | 54.91 | -20.61% | ― | -0.46% | -181.96% |